Cargando…

Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1

OBJECTIVE: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, Wesam, Abd elaziz Alsaid, Aldosoky, Abbas, Awad Saad, Abdel-Aziz, Tarek M, Shoaeir, Mohamed Z, Abd Elazem, Abd Allah S, Sayed, Mohammad Hamdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482965/
https://www.ncbi.nlm.nih.gov/pubmed/36133925
http://dx.doi.org/10.2147/OARRR.S373589
_version_ 1784791567859449856
author Gouda, Wesam
Abd elaziz Alsaid, Aldosoky
Abbas, Awad Saad
Abdel-Aziz, Tarek M
Shoaeir, Mohamed Z
Abd Elazem, Abd Allah S
Sayed, Mohammad Hamdy
author_facet Gouda, Wesam
Abd elaziz Alsaid, Aldosoky
Abbas, Awad Saad
Abdel-Aziz, Tarek M
Shoaeir, Mohamed Z
Abd Elazem, Abd Allah S
Sayed, Mohammad Hamdy
author_sort Gouda, Wesam
collection PubMed
description OBJECTIVE: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people with silent LN (SLN) may have pathological evidence of renal involvement identified by renal biopsy. Monocyte Chemotactic Protein 1 (MCP-1) is a chemotactic factor that promotes leukocyte migration to the kidney. MCP-1 urine levels (uMCP-1) have been demonstrated to be high in individuals with active LN. The purpose of this study was to discover the occurrence of SLN, as well as the possible variations between overt LN (OLN) and SLN across SLE patients based on the histopathological assessment, as well as the role of uMCP-1 in the early detection of SLN. METHODS: An overall of 144 patients with SLE were included in the current research. Patients were subsequently divided into two groups: individuals who did not have clinical evidence of LN (84 patients) and those with OLN (60 patients). All the patients were subjected to the following investigations: uMCP-1, erythrocyte sedimentation rate (ESR), complement C3 (C3), complement C4 (C4), creatinine, albumin/creatinine ratio (uACR), creatinine clearance, quantitative assessment of proteinuria by 24-hour urine proteinuria (24hr UP) and percutaneous renal biopsy. RESULTS: Sixty patients from group I (71.4%) showed glomerular lesions on renal biopsy (SLN), and class II was the predominant class. uMCP-1 had a sensitivity of 95.2% and a specificity of 98% in the detection of SLN, and uMCP-1 values were markedly higher in patients with OLN in comparison to SLN. CONCLUSION: The actual frequency of SLN may be higher than expected. High levels of uMCP-1 may have warranted the early activity of LN. uMCP-1 can be used as a non-invasive, useful tool for the prediction of LN.
format Online
Article
Text
id pubmed-9482965
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94829652022-09-20 Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1 Gouda, Wesam Abd elaziz Alsaid, Aldosoky Abbas, Awad Saad Abdel-Aziz, Tarek M Shoaeir, Mohamed Z Abd Elazem, Abd Allah S Sayed, Mohammad Hamdy Open Access Rheumatol Original Research OBJECTIVE: Lupus nephritis (LN) affects almost half of all individuals with systemic lupus erythematosus (SLE). Overt LN (OLN) symptoms might vary from asymptomatic microscopic hematuria to renal failure. However, when there are no clinical or laboratory indicators of renal involvement, some people with silent LN (SLN) may have pathological evidence of renal involvement identified by renal biopsy. Monocyte Chemotactic Protein 1 (MCP-1) is a chemotactic factor that promotes leukocyte migration to the kidney. MCP-1 urine levels (uMCP-1) have been demonstrated to be high in individuals with active LN. The purpose of this study was to discover the occurrence of SLN, as well as the possible variations between overt LN (OLN) and SLN across SLE patients based on the histopathological assessment, as well as the role of uMCP-1 in the early detection of SLN. METHODS: An overall of 144 patients with SLE were included in the current research. Patients were subsequently divided into two groups: individuals who did not have clinical evidence of LN (84 patients) and those with OLN (60 patients). All the patients were subjected to the following investigations: uMCP-1, erythrocyte sedimentation rate (ESR), complement C3 (C3), complement C4 (C4), creatinine, albumin/creatinine ratio (uACR), creatinine clearance, quantitative assessment of proteinuria by 24-hour urine proteinuria (24hr UP) and percutaneous renal biopsy. RESULTS: Sixty patients from group I (71.4%) showed glomerular lesions on renal biopsy (SLN), and class II was the predominant class. uMCP-1 had a sensitivity of 95.2% and a specificity of 98% in the detection of SLN, and uMCP-1 values were markedly higher in patients with OLN in comparison to SLN. CONCLUSION: The actual frequency of SLN may be higher than expected. High levels of uMCP-1 may have warranted the early activity of LN. uMCP-1 can be used as a non-invasive, useful tool for the prediction of LN. Dove 2022-09-14 /pmc/articles/PMC9482965/ /pubmed/36133925 http://dx.doi.org/10.2147/OARRR.S373589 Text en © 2022 Gouda et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gouda, Wesam
Abd elaziz Alsaid, Aldosoky
Abbas, Awad Saad
Abdel-Aziz, Tarek M
Shoaeir, Mohamed Z
Abd Elazem, Abd Allah S
Sayed, Mohammad Hamdy
Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
title Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
title_full Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
title_fullStr Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
title_full_unstemmed Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
title_short Silent Lupus Nephritis: Renal Histopathological Profile and Early Detection with Urinary Monocyte Chemotactic Protein 1
title_sort silent lupus nephritis: renal histopathological profile and early detection with urinary monocyte chemotactic protein 1
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482965/
https://www.ncbi.nlm.nih.gov/pubmed/36133925
http://dx.doi.org/10.2147/OARRR.S373589
work_keys_str_mv AT goudawesam silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1
AT abdelazizalsaidaldosoky silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1
AT abbasawadsaad silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1
AT abdelaziztarekm silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1
AT shoaeirmohamedz silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1
AT abdelazemabdallahs silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1
AT sayedmohammadhamdy silentlupusnephritisrenalhistopathologicalprofileandearlydetectionwithurinarymonocytechemotacticprotein1